InsidersTradesSigma
Explore the detailed record of transactions filed by Alsakali Equity AB. Director active across 2 companies, notably Newbury Pharmaceuticals AB. Cumulatively, 2 disclosures have been published. History available since 17 November 2025. The latest transaction was disclosed on 18 November 2025 (Purchase). Regulator: FIN-FSA. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条